Elutia (ELUT) Preferred Stock Liabilities (2019 - 2020)
Elutia (ELUT) reported Preferred Stock Liabilities of $56.6 million for Q3 2020, up 36.66% on a YoY basis from $41.4 million in Q4 2019, and up 26.05% sequentially from $44.9 million in Q2 2020.
Elutia (ELUT) Preferred Stock Liabilities (2019 - 2020) Analysis & Trends
Elutia (ELUT) has 2 years of Preferred Stock Liabilities data on file, last reported at $56.6 million in Q3 2020.
- For the quarter ending Q3 2020, Preferred Stock Liabilities rose 36.66% year-over-year to $56.6 million; the trailing twelve-month figure through Sep 2020 stood at $56.6 million (up 36.66% YoY), and the FY2019 full-year result was $44.4 million, changed N/A from the prior year.
- Preferred Stock Liabilities climbed to $56.6 million in Q3 2020, from $44.9 million in the prior quarter.
- In the past five years, Preferred Stock Liabilities ranged from a high of $56.6 million in Q3 2020 to a low of $41.4 million in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Elutia | 39.99 Mn | 11.50 Mn | 1.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 56.59 Mn |
| Jun 30, 2020 | 44.90 Mn |
| Mar 31, 2020 | 44.90 Mn |
| Dec 31, 2019 | 44.45 Mn |
| Sep 30, 2019 | 41.41 Mn |